I. Trayner

947 total citations
24 papers, 763 citations indexed

About

I. Trayner is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology. According to data from OpenAlex, I. Trayner has authored 24 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 7 papers in Pharmacology. Recurrent topics in I. Trayner's work include Lipoproteins and Cardiovascular Health (10 papers), Pharmacology and Obesity Treatment (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). I. Trayner is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Pharmacology and Obesity Treatment (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). I. Trayner collaborates with scholars based in United Kingdom, Slovakia and Italy. I. Trayner's co-authors include G. R. Thompson, T. A. B. Sanders, David Sullivan, Mark B. Pepys, Frederick C. de Beer, M L Baltz, A.K. Soutar, A. Feinstein, Mahmoud Barbir and Gilbert R. Thompson and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Heart.

In The Last Decade

I. Trayner

24 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Trayner United Kingdom 16 355 258 173 155 131 24 763
Yitzhak Beigel Israel 19 304 0.9× 173 0.7× 110 0.6× 56 0.4× 152 1.2× 50 790
G.B. Quinci Italy 6 395 1.1× 513 2.0× 143 0.8× 65 0.4× 155 1.2× 8 744
C.‐H. Florén Sweden 18 429 1.2× 138 0.5× 296 1.7× 123 0.8× 51 0.4× 47 996
Lars Erik Böttiger Sweden 8 229 0.6× 399 1.5× 119 0.7× 73 0.5× 206 1.6× 12 701
Hiroyuki Sugiuchi Japan 14 355 1.0× 411 1.6× 128 0.7× 83 0.5× 181 1.4× 43 1.0k
Strong Jp United States 16 320 0.9× 172 0.7× 113 0.7× 82 0.5× 416 3.2× 35 925
C B Marenah United Kingdom 17 289 0.8× 167 0.6× 49 0.3× 112 0.7× 76 0.6× 30 670
D Mendelsohn South Africa 15 349 1.0× 165 0.6× 53 0.3× 133 0.9× 68 0.5× 50 664
Maurice A. Mishkel Canada 14 312 0.9× 355 1.4× 133 0.8× 184 1.2× 222 1.7× 21 930
Nancy Phillips United States 12 522 1.5× 501 1.9× 120 0.7× 42 0.3× 266 2.0× 14 984

Countries citing papers authored by I. Trayner

Since Specialization
Citations

This map shows the geographic impact of I. Trayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Trayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Trayner more than expected).

Fields of papers citing papers by I. Trayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Trayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Trayner. The network helps show where I. Trayner may publish in the future.

Co-authorship network of co-authors of I. Trayner

This figure shows the co-authorship network connecting the top 25 collaborators of I. Trayner. A scholar is included among the top collaborators of I. Trayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Trayner. I. Trayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kehely, Anne, Mark MacMahon, Richard Wray, et al.. (1993). Bezafibrate and Simvastatin: An Effective and Safe Combination to Treat Mixed Hyperlipidaemia. Clinical Science. 85(s29). 20P–20P. 1 indexed citations
2.
Griffin, Michael, et al.. (1992). Long-term use of depot-norethisterone enanthate: Effect on blood lipid fractions. Contraception. 46(1). 49–60. 7 indexed citations
3.
Kehely, Anne, et al.. (1990). High prevalence of raised levels of LP(a) and apoB after cardiac transplantation. Atherosclerosis. 85(1). 97–97. 1 indexed citations
4.
Fotherby, K., et al.. (1987). Metabolic investigations with femodene — An oral contraceptive containing gestodene and ethinyloestradiol. Contraception. 35(4). 323–337. 19 indexed citations
5.
Thompson, Gilbert R., et al.. (1986). Efficacy of Mevinolin as Adjuvant Therapy for Refractory Familial Hypercholesterolaemia. QJM. 60(232). 803–11. 37 indexed citations
6.
Sugrue, D., et al.. (1985). Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.. Heart. 53(3). 265–268. 23 indexed citations
7.
Rowe, Ian, A.K. Soutar, I. Trayner, et al.. (1984). Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins.. The Journal of Experimental Medicine. 159(2). 604–616. 38 indexed citations
8.
Murphy, Michael, D. Sugrue, I. Trayner, et al.. (1984). Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.. Heart. 51(6). 589–594. 18 indexed citations
9.
Rowe, Ian, Anne K. Soutar, I. Trayner, G. R. Thompson, & M B Pepys. (1984). Circulating human C-reactive protein binds very low density lipoproteins.. PubMed. 58(1). 237–44. 54 indexed citations
10.
Elder, M.G., et al.. (1984). Effect of a new contraceptive ring releasing 20μg levonorgestrel daily on blood lipid levels and glucose tolerance. Contraception. 30(1). 55–60. 6 indexed citations
11.
Lawson, P M, I. Trayner, J Rosenstock, & E. M. Kohner. (1984). The effect of continuous subcutaneous insulin infusion on serum lipids.. PubMed. 10(4). 239–44. 8 indexed citations
12.
Ribeiro, Paula, R.K. Walesby, Scott D. Edmondson, et al.. (1983). COLLAGEN CONTENT OF ATHEROSCLEROTIC ARTERIES IS HIGHER IN SMOKERS THAN IN NON-SMOKERS. The Lancet. 321(8333). 1070–1073. 16 indexed citations
13.
Beer, Frederick C. de, A.K. Soutar, M L Baltz, et al.. (1982). Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.. The Journal of Experimental Medicine. 156(1). 230–242. 148 indexed citations
14.
Howard, G, et al.. (1982). SOME METABOLIC EFFECTS OF LONG-TERM USE OF THE INJECTABLE CONTRACEPTIVE NORETHISTERONE OENANTHATE. The Lancet. 319(8269). 423–425. 17 indexed citations
15.
Fotherby, K., et al.. (1982). Effect of injectable norethisterone oenanthate (Norigest) on blood lipid levels. Contraception. 25(4). 435–446. 8 indexed citations
16.
Sugrue, D., Gilbert R. Thompson, C M Oakley, I. Trayner, & R. E. Steiner. (1981). Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia.. BMJ. 283(6303). 1358–1360. 19 indexed citations
17.
Thompson, G. R., et al.. (1980). Effect of lipoprotein concentration and lecithin: cholesterol acyltransferase activity on cholesterol esterification in human plasma after plasma exchange. European Journal of Clinical Investigation. 10(1). 45–48. 8 indexed citations
18.
Kaufman, Susan, et al.. (1980). Effect of jogging on serum low density lipoprotein cholesterol.. PubMed. 7(2). 99–108. 8 indexed citations
19.
Trayner, I., Timothy A. Welborn, A. H. Rubenstein, & T. Russell Fraser. (1967). SERUM AND URINE INSULIN IN LATE PREGNANCY AND IN A FEW PREGNANT LATENT DIABETICS. Journal of Endocrinology. 37(4). 443–453. 17 indexed citations
20.
Samaan, N. A., et al.. (1965). Effect of Obesity and of Starvation on Insulin Activity. BMJ. 1(5443). 1153–1156. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yitzhak Beigel Breakdown of academic impact, for papers by G.B. Quinci Breakdown of academic impact, for papers by C.‐H. Florén Breakdown of academic impact, for papers by Lars Erik Böttiger Breakdown of academic impact, for papers by Hiroyuki Sugiuchi Breakdown of academic impact, for papers by Strong Jp Breakdown of academic impact, for papers by C B Marenah Breakdown of academic impact, for papers by D Mendelsohn Breakdown of academic impact, for papers by Maurice A. Mishkel Breakdown of academic impact, for papers by Nancy Phillips
Rankless by CCL
2026